Biocon Limited announced significant management changes effective April 01, 2026, following its strategic plan to integrate Biocon Biologics. Key changes include the resignation of Mr. Siddharth Mittal as CEO & MD, succeeded by Mr. Shreehas Pradeep Tambe. Mr. Mukesh Kamath also steps down as Interim CFO, replaced by Mr. Kedar Narayan Upadhye. The board approved new designations for several Key Managerial Personnel and senior executives, detailed across multiple annexures.
Leadership Changes Approved by the Board
Biocon Limited announced several key leadership transitions following its Board meeting held on Friday, March 27, 2026. These changes are integral to the integration plan announced previously regarding Biocon Biologics Limited.
Chief Executive Officer and Managing Director Transition
The Board accepted the resignation of Mr. Siddharth Mittal (DIN: 03230757) from the roles of Chief Executive Officer and Managing Director, effective March 31, 2026. Mr. Mittal will transition into another leadership role within the Biocon Group.
Following recommendations, the Board approved the appointment of Mr. Shreehas Pradeep Tambe (DIN: 09796480), currently CEO & MD of Biocon Biologics, as an Additional Director effective April 01, 2026. He will subsequently take over as the new CEO & MD (Key Managerial Personnel) for a period of five years starting April 01, 2026, pending shareholder approval.
Chief Financial Officer Transition
The resignation of Mr. Mukesh Kamath as Interim Chief Financial Officer was accepted, effective March 31, 2026, as he moves to another role within the Biocon Group.
The Board approved the appointment of Mr. Kedar Narayan Upadhye, CFO of Biocon Biologics, as the Chief Financial Officer (KMP) of Biocon, effective April 01, 2026.
Appointment of Key Managerial Personnel (KMP)
Based on committee recommendations, Mr. Akhilesh Nand, Company Secretary of Biocon Biologics, was designated as Head, Governance, Risk and Compliance, and appointed as a Key Managerial Personnel, effective April 01, 2026.
Changes in Senior Management Personnel
In alignment with organizational structure changes, the Board also approved new designations and cessations for Senior Management Personnel, effective April 01, 2026, for new appointments, and effective March 31, 2026, for cessations.
New Designations (Effective April 01, 2026)
- Mr. Naveen Narayanan (Head, Global Head of HR of BBL) designated as Chief Human Resources Officer of the Company.
- Mr. Mandar Shrikant Ghatnekar (Global Head of IT & Digital Transformation of BBL) designated as Chief Technology Officer of the Company.
Cessations (Effective March 31, 2026)
The following individuals ceased to be Senior Management Personnel:
- Abhijit Zutshi (Chief Commercial Officer)
- Manoj Kumar Pananchukunnath (Chief Scientific Officer)
- Arun Kumar Gupta (Chief Operating Officer)
- Maninder Kapoor Puri (Head, Human Resources)
- Nitin Tiwari (Head, Quality)
- Vishal Nayyar (Head, Supply Chain Management)
- Amit Kaptain (Head, Commercials, API)
Authorized Personnel for Disclosures
The Board also severally authorized the following Key Managerial Personnel (KMP) to determine materiality and make disclosures starting April 01, 2026:
| Designation | Personnel |
|---|---|
| Executive Chairperson | Ms. Kiran Mazumdar-Shaw |
| CEO & Managing Director | Mr. Shreehas Pradeep Tambe |
| Chief Financial Officer | Mr. Kedar Narayan Upadhye |
| Head, Governance, Risk and Compliance | Mr. Akhilesh Nand |
| Company Secretary | Mr. Rajesh Umakant Shanoy |
The meeting commenced at 10:50 A.M. and concluded at 11:35 A.M.
Source: BSE
